Iterum Therapeutics plc
ITRM
$0.6833
-$0.0377-5.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.08M | -22.56M | -24.77M | -30.55M | -28.34M |
| Total Depreciation and Amortization | 969.00K | 626.00K | 284.00K | 463.00K | 891.00K |
| Total Amortization of Deferred Charges | 1.34M | 1.91M | 2.29M | 4.28M | 2.32M |
| Total Other Non-Cash Items | 8.95M | 8.52M | 8.16M | 4.06M | -9.22M |
| Change in Net Operating Assets | -1.93M | -5.24M | -12.73M | -13.61M | -7.60M |
| Cash from Operations | -14.74M | -16.75M | -26.77M | -35.36M | -41.95M |
| Capital Expenditure | -2.00K | -4.00K | -2.00K | -2.00K | 1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.80M | 11.00M | 18.21M | 30.63M | 25.29M |
| Cash from Investing | 6.80M | 11.00M | 18.21M | 30.63M | 25.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -14.75M | -14.75M | -- | -- | -- |
| Issuance of Common Stock | 30.78M | 25.83M | 26.69M | 13.40M | 7.98M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.04M | 11.09M | 26.69M | 13.40M | 7.98M |
| Foreign Exchange rate Adjustments | -48.00K | -71.00K | -75.00K | -87.00K | -82.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.05M | 5.26M | 18.05M | 8.59M | -8.76M |